157 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Downtrend
Article Searches
Here's Why Novo Nordisk A/S Gained 12% in August https://www.fool.com/investing/2017/09/06/heres-why-novo-nordisk-as-gained-12-in-august.aspx?source=iedfolrf0000001 Sep 06, 2017 - Last summer, the diabetes-focused pharmaceutical issued distressing guidance due to pricing pressure worries, but the forecast troubles failed to arrive.
Why MannKind Corporation Popped Today https://www.fool.com/investing/2017/10/02/why-mannkind-corporation-popped-today.aspx?source=iedfolrf0000001 Oct 02, 2017 - Traders cheer after management provided investors with a series of positive updates.
Novo Nordisk (NVO) Presents At 22nd HR Shared Services 7 Outsourcing Summit - Slideshow https://seekingalpha.com/article/4114760-novo-nordisk-nvo-presents-22nd-hr-shared-services-7-outsourcing-summit-slideshow?source=feed_sector_healthcare Oct 19, 2017 - The following slide deck was published by Novo Nordisk A/S in conjunction with this event.
The 3 Best Diabetes Stocks to Buy in 2018 https://www.fool.com/investing/2017/10/30/the-3-best-diabetes-stocks-to-buy-in-2018.aspx?source=iedfolrf0000001 Oct 30, 2017 - Not all diabetes stocks are created equally.
MannKind CEO Michael Castagna on What's Ahead for the Biotech https://www.fool.com/investing/2017/11/21/mannkind-ceo-michael-castagna-on-whats-ahead-for-t.aspx?source=iedfolrf0000001 Nov 21, 2017 - A conversation with MannKind's CEO about the biotech's future with Afrezza, payers, partners, and pipeline candidates.
Novo Nordisk (NVO) Investor Presentation - Slideshow https://seekingalpha.com/article/4127163-novo-nordisk-nvo-investor-presentation-slideshow?source=feed_sector_healthcare Nov 22, 2017 - The following slide deck was published by Novo Nordisk A/S in conjunction with this event.
Novo Nordisk (NVO) Investor Presentation - Slideshow https://seekingalpha.com/article/4127164-novo-nordisk-nvo-investor-presentation-slideshow?source=feed_sector_healthcare Nov 22, 2017 - The following slide deck was published by Novo Nordisk A/S in conjunction with this event.
3 Top Pharmaceutical Dividend Stocks to Buy Now https://www.fool.com/investing/2017/12/19/3-top-pharmaceutical-dividend-stocks-to-buy-now.aspx?source=iedfolrf0000001 Dec 19, 2017 - Looking for income from the pharmaceutical industry? Start with these three companies.
Better Buy: GlaxoSmithKline plc vs. Eli Lilly https://www.fool.com/investing/2018/01/21/better-buy-glaxosmithkline-plc-vs-eli-lilly.aspx?source=iedfolrf0000001 Jan 21, 2018 - Both big pharma stocks have growth drivers. But both also come with baggage.
Will Sanofi's Big Hemophilia Deal Pay Off? https://www.fool.com/investing/2018/01/24/will-sanofis-big-hemophilia-deal-pay-off.aspx?source=iedfolrf0000001 Jan 24, 2018 - Sanofi's leap into an undeniably big market could face challenges as treatment evolves.

Pages: 12345678...16

<<<Page 3>